The model's full reasoning — Q2 2022 call → NOWe need answer YES/NO. Need analyze transcript. Need identify if management describes identifiable piece of new business activity already started contributing partway through reported period or starting right now, with partial early slice, fuller run-rate arriving over next few quarters as timing matter. Let's parse transcript. Company Treace Medical, bunion surgery products. Q2 2022 results. Revenue growth 45%. They discuss investments, direct sales force expansion, DTC, new products. Need find specific new contributor already live/just going live, partial period, fuller contribution timing. Potential candidates: - Direct sales force expansion: They ended Q2 with 123 quota-carrying direct reps, up from 81 end of 2021. They say "we are already trending above our previously announced year-end goal of 70% early on here in the third quarter." Also "given strong interest from candidates to join our employee sales team, we now expect to exceed our year-end goal of 150 [indiscernible] sales reps." This is a ramp of direct sales force. Did reported period catch only part? They added reps during Q2, and they are ramping. But is this "new business activity" that has already started contributing? Direct sales reps are hired and contributing, but the full contribution will come as they mature. Management says direct reps typically scale with cost leverage within 24 months. They are investing. But is this a nameable new contributor? It's an expanding sales force, not a single contract. It is already live. Reported results include partial? They added reps throughout period, so yes, but management doesn't explicitly say reported results include only fraction of their normal level? They say "As our direct sales force matures, we look forward to driving expense leverage over time." Also "we're pleased with increasing productivity of our direct sales force. And when combined with our seasonally strong fourth quarter, we look forward to driving increasing leverage..." Hmm. - New product innovations: "On August 3, we announced the full nationwide commercial release of several new product innovations previewed at ACFAS... Lapiplasty 3-in-1 guide, Lapiplasty S4A Anatomic Plating System, and speed release and [indiscernible] release instruments." This is after Q2 (August 3), so not in reported period. But "full nationwide commercial release" just going live.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| WHF | WhiteHorse Finance | Q1 2022 | 2022-05-10 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| MXL | MaxLinear, Inc. | Q2 2017 | 2017-08-08 | C |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
| SHOO | Steven Madden, Ltd. | Q1 2017 | 2017-04-21 | C |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| WTS | Watts Water Technologies, Inc. | Q4 2016 | 2017-02-10 | B |
SHOO · Q1 2017 → YESThe question is about whether management describes a new business activity that has already started contributing partway through the reported period or is starting now, and that the reported results o...YES The transcript describes the Schwartz & Benjamin acquisition as a new contributor that began delivering sales in the reported Q1 period ($14 million, slightly above plan), with the results capturing only its early partial slice. Management explicitly notes that the full-quarter impact will arrive in subsequent quarters (dragging gross margin more going forward), 2017 will be breakeven-to-EPS, and meaningful profit contribution starts in 2018—making the fuller run-rate a pure timing matter of integration and ramp rather than any further winning. This meets all three criteria. (Madden NYC and SM Europe are also new launches/JVs with early/modest contributions and growth ahead, but Schwartz & Benjamin is the clearest fit for the exact timing story.) NO for the other items because they are either not yet live (China JV), not described as partial/early-slice (SM Europe international growth), or not framed as timing-driven ramp (Madden NYC modest contribution is positive but 2018+ profit is more about execution than pure timing). The answer is YES.
AFL · Q2 2023 → YESThe question is about whether management describes a new business activity that has already started contributing partway through the reported period or is starting now, and that the reported results o...YES The transcript describes the WINGS cancer insurance product launch in Japan Post (early April, during Q2) as a new, nameable contributor that began transacting mid-period. Management explicitly states it was the "majority contributor" to the 60% cancer sales increase in Q2 versus 2022, 26.6% overall sales premium growth, and notes the reported results captured only an early slice because "right when you launch the product, you'll have an immediate jump in sales in the early months followed by a calming down" with "still much more runway...
PDCO · Q3 2017 → YESThe question is about whether management describes a new business activity that has already started contributing partway through the reported period or is starting now, and that the reported results o...YES The transcript describes Heartland Dental as a new customer relationship that began contributing in January (during the reported Q3 period), with the rollout completed on schedule and the business now "getting close to being fully operational." Management explicitly notes that this was "not a significant contributor to consumable sales in the third quarter" — confirming the reported results captured only a partial, early slice — while highlighting the "outstanding start" and excitement for further growth as the relationship scales.